| 3DDQ: reference: CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases., Bettayeb K, Oumata N, Echalier A, Ferandin Y, Endicott JA, Galons H, Meijer L, Oncogene. 2008 Jun 23;. PMID: 18574471 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).